Chemotherapy of acute leukemia with ara-C Estimated ara-C plasma... | Download Table
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and lymphoma. Skeletal formula. Stock Illustration | Adobe Stock
Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics
Cytarabine chemotherapy, uses, dose & cytarabine side effects
The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect
Principles of Chemotherapy and Chemotherapy Complications zlem Snmez
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia | Leukemia
Bone Marrow Stromal Cells Modulate Mouse ENT1 Activity and Protect Leukemia Cells from Cytarabine Induced Apoptosis | PLOS ONE
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet